-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Gn4tFgIpPijhgvieAIUR0Y+dok4ZZAQt2DxbhGDcGQ3EvNXps30w1H+eYfkVxCS0 WmW9r11zVj3/8LtITdgOww== 0001045969-98-000060.txt : 19980130 0001045969-98-000060.hdr.sgml : 19980130 ACCESSION NUMBER: 0001045969-98-000060 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980129 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UROLOGIX INC CENTRAL INDEX KEY: 0000882873 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411697237 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-48431 FILM NUMBER: 98516922 BUSINESS ADDRESS: STREET 1: 14405 21ST AVE N CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: 6124751400 MAIL ADDRESS: STREET 1: 14405 21ST AVENUE NORTH CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DANN MITCHELL CENTRAL INDEX KEY: 0001013102 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O M DANN & CO STREET 2: 185 B CENTER ST P O BOX 9215 CITY: JACKSON STATE: WY ZIP: 83002 BUSINESS PHONE: 3077333806 MAIL ADDRESS: STREET 1: C/O M DANN & CO STREET 2: 185 B CENTER ST P O BOX 9215 CITY: JACKSON STATE: WY ZIP: 83002 SC 13G/A 1 AMENDMENT NO. 1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1 )* ----- Urologix, Inc. - ------------------------------------------------------------------------------ (Name of Issuer) Common Stock, Par Value $.01 Per Share - ----------------------------------------------------------------------------- (Title of Class of Securities) 917273 10 4 ------------------------------ (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) Page 1 of 3 Pages CUSIP NO. 917273 10 4 13G PAGE 2 OF 3 PAGES - -------------------------- ----- ---------------------
1 NAME OF REPORTING PERSON: Mitchell Dann I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: - ----------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (A) / / (B) / / - ----------------------------------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION The Reporting Person is a citizen of the United States. - ----------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 473,857 SHARES 6 SHARED VOTING POWER BENEFICIALLY -0- OWNED BY 7 SOLE DISPOSITIVE POWER EACH 473,857 REPORTING 8 SHARED DISPOSITIVE POWER PERSON -0- WITH: - ----------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 473,857 - ----------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) / / - ----------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 4.3% - ----------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN - -----------------------------------------------------------------------------------
PAGE 3 OF 3 PAGES ------------------- ITEM 1. (a) Name of Issuer -------------- The name of the issuer is Urologix, Inc. (b) Address of Issuer's Principal Executive Offices ----------------------------------------------- The address of the principal executive offices of the Issuer is: 14405 21st Avenue North, Minneapolis, MN 55447 ITEM 5. Ownership of Five Percent or Less of a Class -------------------------------------------- As of December 31, 1997, the Reporting Person owned less than 5% of the total number of outstanding shares of Common Stock of the Issuer. SIGNATURE --------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. January 20, 1998 /s/ Mitchell Dann ---------------------------------- Mitchell Dann -----END PRIVACY-ENHANCED MESSAGE-----